A citation-based method for searching scientific literature

David C J Howell, Robin H Johns, Joseph A Lasky, Bin Shan, Chris J Scotton, Geoffrey J Laurent, Rachel C Chambers. Am J Pathol 2005
Times Cited: 156







List of co-cited articles
1335 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.
Chris J Scotton, Malvina A Krupiczojc, Melanie Königshoff, Paul F Mercer, Y C Gary Lee, Naftali Kaminski, John Morser, Joseph M Post, Toby M Maher, Andrew G Nicholson,[...]. J Clin Invest 2009
219
39

Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.
R Gisli Jenkins, Xiao Su, George Su, Christopher J Scotton, Eric Camerer, Geoffrey J Laurent, George E Davis, Rachel C Chambers, Michael A Matthay, Dean Sheppard. J Clin Invest 2006
230
30

Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.
D C Howell, N R Goldsack, R P Marshall, R J McAnulty, R Starke, G Purdy, G J Laurent, R C Chambers. Am J Pathol 2001
133
24


Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis.
Paul F Mercer, Robin H Johns, Chris J Scotton, Malvina A Krupiczojc, Melanie Königshoff, David C J Howell, Robin J McAnulty, Anuk Das, Andrew J Thorley, Terry D Tetley,[...]. Am J Respir Crit Care Med 2009
80
25




Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis.
S Imokawa, A Sato, H Hayakawa, M Kotani, T Urano, A Takada. Am J Respir Crit Care Med 1997
108
18

Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits.
Andreas Günther, Norbert Lübke, Monika Ermert, Ralph T Schermuly, Norbert Weissmann, Andreas Breithecker, Philipp Markart, Clemens Ruppert, Karin Quanz, Leander Ermert,[...]. Am J Respir Crit Care Med 2003
127
18

Anticoagulant therapy for idiopathic pulmonary fibrosis.
Hiroshi Kubo, Katsutoshi Nakayama, Masaru Yanai, Tomoko Suzuki, Mutsuo Yamaya, Mika Watanabe, Hidetada Sasaki. Chest 2005
293
17


Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
Malgorzata Wygrecka, Grazyna Kwapiszewska, Ewa Jablonska, Susanne von Gerlach, Ingrid Henneke, Dariusz Zakrzewicz, Andreas Guenther, Klaus T Preissner, Philipp Markart. Am J Respir Crit Care Med 2011
60
28

A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.
Imre Noth, Kevin J Anstrom, Sara Bristol Calvert, Joao de Andrade, Kevin R Flaherty, Craig Glazer, Robert J Kaner, Mitchell A Olman. Am J Respir Crit Care Med 2012
290
17

Role of thrombin in pulmonary fibrosis.
N A Hernández-Rodríguez, A D Cambrey, N K Harrison, R C Chambers, A J Gray, A M Southcott, R M duBois, C M Black, M F Scully, R J McAnulty. Lancet 1995
109
16

Coagulation cascade proteinases in lung injury and fibrosis.
Rachel C Chambers, Chris J Scotton. Proc Am Thorac Soc 2012
52
30

'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
Nicole C Kaneider, Andrew J Leger, Anika Agarwal, Nga Nguyen, George Perides, Claudia Derian, Lidija Covic, Athan Kuliopulos. Nat Immunol 2007
173
15

Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation.
Olivier P Blanc-Brude, Fabienne Archer, Patricia Leoni, Claudia Derian, Steven Bolsover, Geoffrey J Laurent, Rachel C Chambers. Exp Cell Res 2005
75
18

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
14

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
14

Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation.
Gerald S Horan, Susan Wood, Victor Ona, Dan Jun Li, Matvey E Lukashev, Paul H Weinreb, Kenneth J Simon, Kyungmin Hahm, Normand E Allaire, Nicola J Rinaldi,[...]. Am J Respir Crit Care Med 2008
271
13

Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1.
R C Chambers, K Dabbagh, R J McAnulty, A J Gray, O P Blanc-Brude, G J Laurent. Biochem J 1998
124
13





Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis.
I Kotani, A Sato, H Hayakawa, T Urano, Y Takada, A Takada. Thromb Res 1995
144
12

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
12

Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
Cong Lin, Janwillem Duitman, Joost Daalhuisen, Marieke Ten Brink, Jan von der Thüsen, Tom van der Poll, Keren Borensztajn, C Arnold Spek. Thorax 2014
32
37


Coagulation cascade proteases and tissue fibrosis.
R C Chambers, G J Laurent. Biochem Soc Trans 2002
74
14

Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.
Galina S Bogatkevich, Anna Ludwicka-Bradley, Paul J Nietert, Tanjina Akter, Joanne van Ryn, Richard M Silver. Arthritis Rheum 2011
75
14

MMP expression and abnormal lung permeability are important determinants of outcome in IPF.
S McKeown, A G Richter, C O'Kane, D F McAuley, D R Thickett. Eur Respir J 2009
108
11

Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.
Galina S Bogatkevich, Anna Ludwicka-Bradley, Richard M Silver. Arthritis Rheum 2009
67
14

PAR3 is a cofactor for PAR4 activation by thrombin.
M Nakanishi-Matsui, Y W Zheng, D J Sulciner, E J Weiss, M J Ludeman, S R Coughlin. Nature 2000
410
10

Protease-activated receptors: contribution to physiology and disease.
Valeria S Ossovskaya, Nigel W Bunnett. Physiol Rev 2004
810
10

The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.
Andrew M Tager, Peter LaCamera, Barry S Shea, Gabriele S Campanella, Moisés Selman, Zhenwen Zhao, Vasiliy Polosukhin, John Wain, Banu A Karimi-Shah, Nancy D Kim,[...]. Nat Med 2008
475
10

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.
Roderick J Phillips, Marie D Burdick, Kurt Hong, Marin A Lutz, Lynne A Murray, Ying Ying Xue, John A Belperio, Michael P Keane, Robert M Strieter. J Clin Invest 2004
760
10

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.
J S Munger, X Huang, H Kawakatsu, M J Griffiths, S L Dalton, J Wu, J F Pittet, N Kaminski, C Garat, M A Matthay,[...]. Cell 1999
10

Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis.
M A Cunningham, E Rondeau, X Chen, S R Coughlin, S R Holdsworth, P G Tipping. J Exp Med 2000
157
10

Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.
N Hattori, J L Degen, T H Sisson, H Liu, B B Moore, R G Pandrangi, R H Simon, A F Drew. J Clin Invest 2000
215
10

Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
H Yasui, E C Gabazza, S Tamaki, T Kobayashi, O Hataji, H Yuda, S Shimizu, K Suzuki, Y Adachi, O Taguchi. Am J Respir Crit Care Med 2001
117
10

Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation.
Keren Borensztajn, Jurriën Stiekema, Sebastiaan Nijmeijer, Pieter H Reitsma, Maikel P Peppelenbosch, C Arnold Spek. Am J Pathol 2008
93
9

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.
Kevin K Kim, Matthias C Kugler, Paul J Wolters, Liliane Robillard, Michael G Galvez, Alexis N Brumwell, Dean Sheppard, Harold A Chapman. Proc Natl Acad Sci U S A 2006
885
9



Signal transduction by protease-activated receptors.
Unice J K Soh, Michael R Dores, Buxin Chen, JoAnn Trejo. Br J Pharmacol 2010
200
9


PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation.
Stefano Fiorucci, Elisabetta Antonelli, Eleonora Distrutti, Beatrice Severino, Roviezzo Fiorentina, Monia Baldoni, Giuseppe Caliendo, Vincenzo Santagada, Antonio Morelli, Giuseppe Cirino. Hepatology 2004
123
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.